Respiratory Devices Market Size, Share & Trends | Industry Analysis Report, 2026

Respiratory Devices Market: Overview

As per a report published by the National Institutes of Health (NIH), approximately 12 million adult population is diagnosed with Chronic Obstructive Pulmonary Disease (COPD) annually in the U.S. Further, 120, 000 people die of the cause. As per a statistics provided by Global Asthma Network (GAN), approximately 334 million are, reportedly, suffering from COPD across the globe. In addition, as per data given by the WHO, 3 million people die due to COPD around the world.

Every report by prominent health organization is signaling towards growing incidence of Chronic Obstructive Pulmonary Disease across the world and its adverse impact on health of the people. Some of the significant cases of COPD include respiratory allergies, asthma, occupational lung diseases, and pulmonary hypertension. Prevalence of such diseases is witnessed in middle- and low-income countries.

Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28073

Dramatic rise in respiratory diseases and subsequent increase in patient pool due to COPD are major factors accelerating uptake of respiratory therapy and respiratory therapy devices. Use of respiratory devices minimizes the risk of heart failure, enhance breathing patterns, and improves mental stamina.

These factors, altogether, are contributing to expansion of the respiratory devices market.

As per a report published by Transparency Market Research, the respiratory devices market is anticipated to growth at a moderate CAGR of 6.5% between 2018 and 2026 (forecast period). In the year 2017, the respiratory devices market stood at a value of US $ 17 billion. If the market scales at predicted CAGR, then the market size is projected to grow equivalent to US$ 31.0 Bn by the end of 2026.

Rising prevalence of sleep apnea and COPD, healthy competition among key player, investment from various stakeholders are major driving factors likely to fuel the global respiratory device and uncertain regulations by government bodies may interfere with the market growth during the forecast period.

Request the Coronavirus Impact Analysis on this Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=28073

Market Players Focusing to Diversify Product Portfolio in order to Gain Wide Customer Traction

Rising awareness regarding application of respiratory devices and associated benefits is expected to boost the market in coming years. Adoption of on-demand and continuous Portable Oxygen Concentrator (POC) in a wide range of applications including emergency medicine is emerging as a fresh growth prospect for expansion of the global respiratory devices market.

Registering the application areas, players operating in the global market are consistently working to bring innovation in the product, providing efficient solution and on subsequently reducing the price of units.

Some of the prominent key players operating in the oxygen therapy devices market are ResMed, Koninklijke Philips N.V, and Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries, among others

These companies are introducing products on basis of clinical urgency for greater mobility support for elderly population and growing demand for the portable technology by consumers. Diversified product portfolio is anticipated to gain wide customer traction.

Buy _ Research Report Now - https://www.transparencymarketresearch.com/checkout.php?rep_id=28073&ltype=S

Advent of Technologically Advanced Devices Provide Fresh Growth Prospects to Oxygen Delivery Devices

Further, advent of technologically respiratory devices, which offers efficient patient is projected to accelerate the market growth. Technologically advancement in delivery devices has resulted in integration of sensors coupled with pulse dose meters. These devices enable to regulate flow of the oxygen. Adoption of respiratory therapy is growing significantly. The growth rate is attributed to the potential benefits offered by the devices. These benefits include faster response rate, efficient dosing, controlled flow, and greater reliability and durability. These aforementioned factors are likely to propel the industry expansion process.

Growing prevalence of respiratory diseases such as sleep apnea and Chronic Obstructive Pulmonary disorder is anticipated to boost market growth. As per a report published by the WHO, nearly 64 million people across the globe suffers from mild to severe COPD. In addition, COPD is found to be third leading cause of death across the world. Rising demand for protracted treatment and emergency treatment associated with lung diseases in children and adults are likely to boost the market growth during the forecast period.

Further, respiratory therapeutics devices are preferred by medical professionals and physicians for treatment of various types of respiratory disorders. These devices provide immediate medical intervention in case of acute and chronic patient care.